Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Gasparoto, Thais Helena ^a   De Oliveira, Carine Ervolino ^a   De Freitas, Luisa Thomazini ^a   Pinheiro, Claudia Ramos ^a   Hori, Juliana Issa ^a   Garlet, Gustavo Pompermaier ^a   Cavassani, Karen Angélica ^b   Schillaci, Roxana ^c   Da Silva, João Santana ^a   Zamboni, Dario Simões ^a   Campanelli, Ana Paula ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CASPASE RECRUITMENT DOMAIN; DIMETHYLBENZ[A]ANTHRACENE; ELASTASE; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 7,12 DIMETHYLBENZ[A]ANTHRACENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD45RB+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; LYMPH NODE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PAPILLOMA; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; IMMUNOLOGY; KNOCKOUT MOUSE; PHYSIOLOGY; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, SQUAMOUS CELL; FEMALE; INFLAMMASOMES; LYMPH NODES; MICE, INBRED C57BL; MICE, KNOCKOUT; PAPILLOMA; SKIN NEOPLASMS;

EID: 84907479663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107170     Document Type: Article

References (55)

1. Rangwala S, Tsai KY (2011) Roles of the immune system in skin cancer. Br J Dermatol 165: 953-965.
2. Uppaluri R, Dunn GP, Lewis JS Jr (2008) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun. 8:16.
3. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 3: 991-998.
4. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148.
5. Duray A, Demoulin S, Hubert P, Delvenne P, Saussez S (2010) Immune suppression in head and neck cancers: a review. Clin Dev Immunol 2010: 701657. Available: http://www.hindawi.com/journals/jir/2010/701657/. Accessed 10 February 2014.
6. Gasparoto TH, de Souza Malaspina TS, Benevides L, de Melo EJ Jr, Costa MR, et al. (2010) Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer Immunol Immunother 59:819-828.
7. Ramos RN, Oliveira CE, Gasparoto TH, Malaspina TS, Belai EB, et al. (2012) CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses. Carcinogenesis 33:902-909.
8. Berger-Achituv S, Brinkmann V, Abed UA, Kühn LI, Ben-Ezra J, et al. (2013) A proposed role for neutrophil extracellular traps in cancer immunoediting. FrontImmunol 4: 48. Available:http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00048/full. Accessed 10 February 2014.
9. Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, et al. (2013) Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 123:3446-3458.
10. Zitvogel L, Kepp O, Galluzzi L, Kroemer G (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 13:343-351.
11. Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137-161.
12. Davis BK, Wen H, Ting JP (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29:707-735.
13. Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13:397-411.
14. Dinarello CA (2012) Membrane interleukin-18 revisits membrane IL-1a in Thelper type 1 responses. Eur J Immunol 42:1385-1387.
15. Chen L, Park SM, Tumanov AV, Hau A, Sawada K, et al. (2010) CD95 promotes tumour growth. Nature 465:492-496.
16. Oleinika K, Nibbs RJ, Graham GJ, Fraser AR (2013) Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clin Exp Immunol 171:36-45.
17. Malhotra A, Shanker A (2011) NK cells: immune cross-talk and therapeutic implications. Immunotherapy 3:1143-1166.
18. Dudek AM, Garg AD, Krysko DV, De Ruysscher D, Agostinis P (2013) Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev 24:319-333.
19. Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51-72.
20. Sutterwala FS, Flavell RA (2009) NLRC4/IPAF: a CARD carrying member of the NLR family. Clin Immunol 130:2-6.
21. Pedra JH, Cassel SL, Sutterwala FS (2009) Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 21:10-16.
22. Mariathasan S1, Newton K, Monack DM, Vucic D, French DM, et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and NLRC4. Nature 430: 213-218.
23. Latz E (2010) The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 22: 28-33.
24. Aymeric L, Apetoh L, Ghiringhelli F, Tesniere A, Martins I, et al. (2010) Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 70: 855-858.
25. Chow MT, Sceneay J, Paget C, Wong CS, Duret H, et al. (2012) NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res 72:5721-5732.
26. Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, et al. (2012) Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci U S A 109: 18384-18389.
27. Hong S, Hwang I, Lee YS, Park S, Lee WK, et al. (2013) Restoration of ASC expression sensitizes colorectal cancer cells to genotoxic stress-induced caspaseindependent cell death. Cancer Lett 331:183-191.
28. Pomié C, Ménager-Marcq I, van Meerwijk JP (2008) Murine CD8+ regulatory T lymphocytes: the new era. Hum Immunol. 69:708-714.
29. Wood KJ, Bushell A, Hester J (2012) Regulatory immune cells in transplantation. Nat Rev Immunol 12: 417-30.
30. Ferrer IR, Hester J, Bushell A, Wood KJ (2014) Induction of transplantation tolerance through regulatory cells: from mice to men. Immunol Rev 258:102-16
31. Seki I, Suzuki M, Miyasaka N, Kohsaka H (2010) Expression of CD45 isoforms correlates with differential proliferative responses of peripheral CD4+ and CD8+ T cells. Immunol Lett 29: 39-46.
32. Gubser PM, Bantug GR, Razik L, Fischer M, Dimeloe S, et al. (2013) Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol 14 (10):1064-1072.
33. Gasparoto TH, de Oliveira CE, de Freitas LT, Pinheiro CR, Ramos RN, et al. (2012) Inflammatory events during murine squamous cell carcinoma development. J Inflamm (Lond) 9: 46. Available: http://www.journal-inflammation.com/content/9/1/46. Accessed 26 November 2012.
34. Stojanovic A, Correia MP, Cerwenka A (2013) Shaping of NK cell responses by the tumor microenvironment. Cancer Microenviron 6:135-146.
35. Brilot F, Strowig T, Munz C (2008) NK cells interactions with dendritic cells shape innate and adaptive immunity. Front Biosci 13:6443-6454.
36. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12:239-252.
37. Seki S, Nakashima H, Nakashima M, Kinoshita M (2011) Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8CD122 T cells. Clin Dev Immunol 2011: 868345. Available http://www.hindawi.com/journals/jir/2011/868345/. Accessed 10 February 2014.
38. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, et al. (2010) IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 6:e1000661.Availablehttp://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000661. Accessed 10 February 2014.
39. Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:20-38.
40. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, et al. (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11: 395-402.
41. Dostert C, Ludigs K, Guarda G (2013) Innate and adaptive effects of inflammasomes on T cell responses. Curr Opin Immunol 25:359-365.
42. Dungan LS, Mills KH (2011) Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17. Cytokine 56:126-132.
43. Mocellin S, Rossi CR, Pilati P, Nitti D (2005) Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 16:35-53.
44. Chan CW, Housseau F (2008) The 'kiss of death' by dendritic cells to cancer cells. Cell Death Differ 15:58-69.
45. Dobrzanski MJ (2013) Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy. Front Oncol 3: 63. Available: http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00063/full. Accessed 02 February 2014.
46. Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480: 480-489.
47. Narayan S, Kolly L, So A, Busso N (2011) Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation. Immunology 134:33-40.
48. Hotta K, Sho M, Fujimoto K, Shimada K, Yamato I, et al. (2011) Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer 105: 1191-1196.
49. Beynon V, Quintana FJ, Weiner HL (2012) Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling. PLoS One 7:e39576. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0039576. Accessed 25 January 2014.
50. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM (2001) IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFNgamma production. Nat Immunol 2: 157-164.
51. Beinke S, Ley SC (2004) Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 382: 393-409.
52. Gröne A (2002) Keratinocytes and cytokines. Vet Immunol Immunopathol 88:1-12.
53. Lavieri R, Piccioli P, Carta S, Delfino L, Castellani P, et al. (2014) TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production. J Immunol 192: 5373-5381.
54. Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, et al. (2008) Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. ProcNatlAcadSci U S A 105: 652-656.
55. Schön MP, Schön M (2008) TLR7 and TLR8 as targets in cancer therapy. Oncogene 27:190-199.